Cumberland Pharmaceuticals (CPIX) Operating Expenses (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Operating Expenses across 17 years of filings, most recently posting $3.3 million for Q2 2026.

• In Q2 2026, Operating Expenses fell 4.95% year-over-year to $3.3 million; the TTM figure through Jun 2026 stood at $40.9 million (up 10.59% YoY), while the FY2025 annual figure was $47.3 million, up 6.8% from the prior year.
• Operating Expenses came in at $3.3 million for Q2 2026 at Cumberland Pharmaceuticals, down from $12.3 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $15.5 million in Q4 2023 to a low of $3.3 million in Q2 2026.
• Average Operating Expenses over 5 years is $10.9 million, with a median of $11.1 million recorded in 2022.
• Year-over-year, Operating Expenses surged 36.23% in 2023 and plunged 67.81% in 2025.
• Over 5 years, Operating Expenses stood at $11.4 million in 2022, then soared by 36.23% to $15.5 million in 2023, then fell by 20.95% to $12.3 million in 2024, then gained by 22.58% to $15.0 million in 2025, then sank by 77.89% to $3.3 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $3.3 million in Q2 2026, $12.3 million in Q1 2026, and $15.0 million in Q4 2025.